Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends
about
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@ast
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@en
Biologic Disease-Modifying Ant ...... xpenditures, and Price Trends.
@nl
type
label
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@ast
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@en
Biologic Disease-Modifying Ant ...... xpenditures, and Price Trends.
@nl
prefLabel
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@ast
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@en
Biologic Disease-Modifying Ant ...... xpenditures, and Price Trends.
@nl
P2860
P1476
Biologic Disease-Modifying Ant ...... Expenditures, and Price Trends
@en
P2093
Christopher B Atzinger
Jeff J Guo
P2860
P577
2017-02-01T00:00:00Z